Skip to main content

Table 6 11 C-acetate PET/CT findings resulting in altered treatment strategy

From: 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study

Patient number Localisation pelvic LN metastases Localisation distant metastases Synchronous finding Curative→additional RT Curative→non-curative RT
1 Iliac int/ext Paraaortal LN - - Palliative RT
2 Iliac ext Skeletal - - No RT
3 Iliac int/ext - - RT boost 16 Gy -
4 Iliac int/ext   - RT boost 16 Gy -
5 Iliac ext - - RT boost 16 Gy -
6 Iliac com   - RT boost 16 Gy -
7 Iliac int/ext - - RT boost 16 Gy -
8 Obt, iliac int/ext/com   - RT boost 15 Gy -
9 - - HCC with paraaortal LN - No RT
10 Iliac ext   - RT boost 20 Gy -
11 Obt, iliac int/ext/com Paraaortal LN, skeletal - - No RT
12 Pararectal, iliac ext - - RT boost 26 Gy -
13 Pararectal, obt, iliac int/ext/com Paraaortal LN - - Palliative RT
14 Iliac int/ext/com Paraaortal, thoracic, cervical LN - - No RT
15 - Skeletal - - No RT
16 Iliac ext - - RT boost 16 Gy -
17 Iliac ext Skeletal - - No RT
18 - - Aortic aneurysm - No RT
19 Pararectal, iliac int/ext/com Paraaortal, thoracic LN - - No RT
20 Pararectal, obt, iliac ext - - - Palliative RT
Σ 17 8 2 9 11
  1. HCC, hepatocellular carcinoma; LN, lymph nodes; Obt, obturator; RT, radiotherapy.